Tidl Pain Relief Cryo Therapy Original Formula Spray.

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including those related to arthritis, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 12 years of age, it is advised to consult a physician prior to use to determine the appropriate course of action and dosage.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be used while smoking or in proximity to heat or open flame due to the risk of fire hazard.

Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury. Application to wounds, damaged skin, or irritated skin is contraindicated as it may exacerbate the condition. Additionally, the product should not be bandaged or used in conjunction with heating pads or devices, as this may lead to adverse effects. When applying the product, it is essential to spray it away from the nose, eyes, and mouth to minimize the risk of exposure to sensitive areas.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes or mucous membranes. The product should not be applied to wounds, damaged skin, or irritated skin. Additionally, it is advised not to bandage the area after application. Users must wash their hands thoroughly with cool water following use to prevent unintended exposure.

Caution should be exercised to ensure that the product is sprayed away from the nose, eyes, and mouth. The use of heating pads or devices in conjunction with this product is contraindicated.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days.

Side Effects

For external use only. Patients are advised to discontinue use if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days. In such cases, it is recommended that patients consult a healthcare professional for further evaluation and guidance.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Tidl Pain Relief Cryo Therapy Original Formula Spray. (pain relief cryo therapy original formula spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For adolescents and children aged 12 years and older, the recommended dosage is to apply the medication to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this product in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or outline any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist may also be beneficial in guiding the management of the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. It is important to instruct patients to ensure that the child safety spray lock is turned to the off position when the product is not in use to prevent accidental exposure.

Patients should be cautioned to avoid contact with the eyes and mucous membranes, as this may lead to irritation or adverse effects. Additionally, they should be informed not to apply the product to wounds, damaged skin, or irritated skin, as this could exacerbate the condition or lead to further complications.

Healthcare providers should emphasize that the product should not be bandaged after application, and patients should wash their hands thoroughly with cool water after use to minimize any potential skin irritation or transfer of the product to unintended areas.

Furthermore, it is crucial to inform patients that the product should not be used in conjunction with heating pads or devices, as this may alter its effectiveness or safety. Lastly, patients should be instructed to spray the product away from the nose, eyes, and mouth to prevent accidental exposure to sensitive areas.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure. Freezing the product is strictly prohibited, as it may compromise its integrity.

To maintain safety, the product must be kept out of reach of children. Additionally, when the product is not in use, it is crucial to turn the child safety spray lock to the off position to prevent accidental discharge. Proper adherence to these storage and handling guidelines will help ensure the product's efficacy and safety.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children aged 12 years and older. For children under 12 years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Tidl Pain Relief Cryo Therapy Original Formula Spray., including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)